Variant report
Variant | nsv976721 |
---|---|
Chromosome Location | chr12:63608020-63615880 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563389096 | chr12:63612847-63612848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532456376 | chr12:63612859-63612860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551451499 | chr12:63612885-63612886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114741878 | chr12:63612926-63612927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527754860 | chr12:63612959-63612960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7308677 | chr12:63612974-63612975 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs75034892 | chr12:63613411-63613412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546104013 | chr12:63613465-63613466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565129194 | chr12:63613532-63613533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527722552 | chr12:63613536-63613537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541038747 | chr12:63613548-63613549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200231365 | chr12:63613556-63613557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201255687 | chr12:63613557-63613558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs398098250 | chr12:63613564-63613565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79158355 | chr12:63613592-63613593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530157717 | chr12:63613647-63613648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs367800519 | chr12:63613648-63613649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143772055 | chr12:63613771-63613772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187399207 | chr12:63613811-63613812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552873422 | chr12:63613844-63613845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566385250 | chr12:63613906-63613907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191550981 | chr12:63613915-63613916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577294120 | chr12:63613936-63613937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568125755 | chr12:63613952-63613953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537183021 | chr12:63614051-63614052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11174868 | chr12:63614055-63614056 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs577012428 | chr12:63614075-63614076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545772180 | chr12:63614096-63614097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552810211 | chr12:63614100-63614101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572806034 | chr12:63614153-63614154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11174869 | chr12:63614163-63614164 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs184079651 | chr12:63614186-63614187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs61936400 | chr12:63614214-63614215 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs543924536 | chr12:63614219-63614220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189711895 | chr12:63614274-63614275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111965144 | chr12:63614275-63614276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113109586 | chr12:63614287-63614288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs199707139 | chr12:63614326-63614327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568348656 | chr12:63614328-63614329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76372847 | chr12:63614368-63614369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551875694 | chr12:63614377-63614378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141940904 | chr12:63614380-63614381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559151366 | chr12:63614396-63614397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557055959 | chr12:63614400-63614401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570465578 | chr12:63614452-63614453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144342510 | chr12:63614476-63614477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79872114 | chr12:63614494-63614495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572767327 | chr12:63614533-63614534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs41437645 | chr12:63614546-63614547 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs557282090 | chr12:63614592-63614593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17220210 | CNVD |
Osteopoikilosis | 17220210 | CNVD |
short stature | 17220210 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:63612800-63613000 | Enhancers | Fetal Kidney | kidney |
2 | chr12:63613400-63614600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr12:63614000-63615200 | Enhancers | HMEC | breast |
4 | chr12:63614200-63620200 | Enhancers | Liver | Liver |
5 | chr12:63614400-63615000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr12:63614600-63614800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr12:63614600-63615200 | Enhancers | Adipose Nuclei | Adipose |
8 | chr12:63614800-63615000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr12:63615000-63615200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr12:63615200-63616200 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr12:63615200-63616600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |